| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S13277-015-3612-Y |
| P698 | PubMed publication ID | 26025114 |
| P50 | author | Jian-Hong Zhong | Q53141993 |
| P2093 | author name string | Jian-Ping Liu | |
| Mi Li | |||
| Qiang Huang | |||
| Le-Qun Li | |||
| Wei-Ping Yuan | |||
| Hao-Feng Lu | |||
| P2860 | cites work | Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature | Q21563436 |
| An exploratory test for an excess of significant findings | Q24273224 | ||
| Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion | Q36151948 | ||
| Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis | Q38088149 | ||
| Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis | Q53526112 | ||
| Intermediate-stage HCC--upfront resection can be feasible. | Q54671979 | ||
| Cancer stem cells | Q80312237 | ||
| Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma | Q81275056 | ||
| Opinion: the origin of the cancer stem cell: current controversies and new insights | Q81573645 | ||
| Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma | Q87251771 | ||
| P433 | issue | 7 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 4937-4938 | |
| P577 | publication date | 2015-05-31 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection | |
| P478 | volume | 36 |
| Q90634581 | Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p |
| Q41107415 | Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. |
| Q92839085 | β-catenin inhibitors suppress cells proliferation and promote cells apoptosis in PC9 lung cancer stem cells |
Search more.